References
- Syrjala KL, Langer SL, Abrams JR, . Recovery and long-term function after hematopoietic cell transplantation for leukemia or lymphoma. JAMA 2004;291:2335–2343.
- Syrjala KL, Langer SL, Abrams JR, . Late effects of hematopoietic cell transplantation among 10-year adult survivors compared with case-matched controls. J Clin Oncol 2005;23:6596–6606.
- Lee SJ, Fairclough D, Parsons SK, . Recovery after stem-cell transplantation for hematologic diseases. J Clin Oncol 2001;19: 242–252.
- Andresen S, Brandt J, Dietrich S, . The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma. Leuk Lymphoma 2012;53:386–393.
- Hensel M, Kornacker M, Salwender H, . How much rituximab is needed for patients with follicular non-Hodgkin's lymphoma: a multicenter randomized trial comparing 1, 3, or 6 infusions of rituximab added to 6 cycles of chemotherapy (HD2000-TRIAL). Blood 2009;114(Suppl. 1): Abstract 251.
- Kornacker M, Stumm J, Pott C, . Characteristics of relapse after autologous stem-cell transplantation for follicular lymphoma: a long-term follow-up. Ann Oncol 2009;20:722–728.
- Konig HH, Bernert S, Angermeyer MC. Health status of the German population: results of a representative survey using the EuroQol questionnaire. Gesundheitswesen 2005;67:173–182.
- Murray E, Burns J, See Tai S, . Interactive health communication applications for people with chronic disease (review). Cochrane Database Syst Rev 2005;(4):CD004274.
- Syrjala KL, Stover AC, Yi JC, . Development and implementation of an internet-based survivorship care program for cancer survivors treated with hematopoietic stem cell transplantation. J Cancer Surviv 2011;5:292–304.